PRISM Mid-Day Movers: Biotech and New Energy are Today’s Leaders
Myriad Genetics (NASDAQ: MYGN) shares surged today, rising $1.55, or 36.70%, to $5.76 by midday, according to Yahoo Finance’s latest news quote. The rally followed news that the genetic-testing company agreed to sell its Prenatal Health testing business to Labcorp for $210 million in cash plus inventory value. The transaction, expected to close by early 2027, includes the Prequel, Foresight, SneakPeek, and FirstGene products; Myriad said the divestiture would improve its overall revenue growth and profitability profile.
XCF Global (NASDAQ: SAFX) shares climbed up 22.04%, trading near $0.19. The advance extended Monday’s 11.55% gain and followed recent company announcements that it completed its business combination with Southern Energy Renewables and DevvStream and generated more than $12 million in gross product sales during September.
Other Notable Movers:
Cumberland Pharma (CPIX) up 19%
Acumen Pharma (ABOS) up 15%
FiscalNote (NOTE) down -17%
Stock prices and percentage changes are as of 12:25 p.m. ET on October 20, 2026, and are subject to change.
